Artios Pharma is a company focused on developing novel cancer treatments targeting the DNA Damage Response #DDR

Consulting

Artios Pharma

Artios Pharma's headquarters in Cambridge, MA, United States

The New York office focuses on driving strategic partnerships and expanding market presence in the competitive business landscape.

New York

Ian Smith

Colleen Murrett Sadin

Pri Pinnaduwa

Christine Silverstein

Devon McArthur

Graeme Smith

Helen Robinson

John Graham

Sara Busacca

Suraj Menon

Bethany Mason

Robert Heald

Andrea Baldwin

Desiree Headley

Bryony Harrop

Gillian Langford

Emma Stewart

Jamie Datol

Bonni Roark

Raj Chopra

Andrew Tutt

Geoff Higgins

Barbara Dalton

Jonathan Ledermann

Adam Houghton

Johann De Bono

Stephen V. Frye

Kevin Harrington

René Kuijten

Raphael Wisniewski

Chen Yu

Michelle Doig

Nora Brennan

Samantha Truex

Mark Chin

Hakan Goker

Chris Lord

Pierre Legault

Nikola Trbovic

Naseem Amin Md

Harry Finch

Peter Harris

Geoff Shapiro

The Scientific Research and Development team at Artios Pharma is dedicated to advancing innovative cancer therapies by exploring the intricacies of the DNA Damage Response (DDR). This multidisciplinary team, comprising experts in biochemistry, medicinal chemistry, and translational science, collaborates to identify and validate novel drug targets, optimize therapeutic candidates, and conduct rigorous preclinical studies. Their efforts aim to translate groundbreaking scientific discoveries into effective treatments for cancer patients.

Scientific Research and Development

This department provides strategic direction and oversight for the organization.

Leadership

This department oversees the planning and execution of clinical trials and studies to evaluate the efficacy and safety of new treatments.

Clinical Development

The Clinical Development Team at Artios Pharma is responsible for designing and overseeing clinical trials aimed at evaluating the safety and efficacy of novel cancer treatments that target the DNA Damage Response (DDR). Comprised of clinical advisors, consultants, trial managers, and scientists, the team collaborates to ensure the successful execution of clinical protocols, seeks regulatory approvals, and analyzes trial data to advance innovative therapies that improve patient outcomes.

Clinical Development Team

This department focuses on identifying growth opportunities, building partnerships, and driving strategic initiatives to enhance the organization's market presence.

Business Development

This department oversees compliance with regulations and standards in chemistry and quality assurance.

Chemical Regulatory Affairs

Artios Pharma

Org chart

Board & advisors

Teams

Scientific Research and Development

Leadership

Clinical Development

Clinical Development Team

Business Development

Chemical Regulatory Affairs

Offices

Artios Pharma

Org chart

Board & advisors

Teams

Scientific Research and Development

Leadership

Clinical Development

Clinical Development Team

Business Development

Chemical Regulatory Affairs

Offices

Related companies